Corrigendum to ‘Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis’

• Type of Material: Article
• Authors: Steven W. Pipe, University of Michigan; Ben Trzaskoma, Genentech Inc; Miranda Minhas, Genentech Inc; Michaela Lehle, F Hoffmann La Roche Ltd; Richard H. Ko, Genentech Inc; Ling Gao, Analystat Corp; Johnny Mahlangu, University of Witwatersrand; Christine Kempton, Emory University; Craig M. Kessler, Georgetown University; Rebecca Kruse-Jarres, University of Washington
• Language: English
• Date: 2023-05-01
• Publisher: ELSEVIER
• Publication Version: Final Published Version
• Copyright Statement: © 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis. All rights reserved.
• Final Published Version (URL): http://dx.doi.org/10.1016/j.rpth.2023.100191
• Title of Journal or Parent Work: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
• Volume: 7
• Issue: 4
• Start Page: 100191
• End Page: 100191
• Keywords: Life Sciences & Biomedicine; Science & Technology; Cardiovascular System & Cardiology; Hematology; Peripheral Vascular Disease
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

The authors regret the supplementary video was missing from the manuscript. This has now been added.